Overview Dividends

(IRM) Iron Mountain - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46284V1017

Records, Data, Centers, Destruction, Cloud

Other Specialized REITs
Market Cap in USD: 23,467m

IPO / Inception: 1996-01-31
Return 12m vs S&P 500: -31.9%

EPS (Earnings per Share)

EPS CAGR: 6.26%
EPS Trend: 48.8%

Last SUE: 0.27
Qual. Beats: 0

Revenue

Rev. CAGR: 11.67%
Rev. Trend: 98.7%

Last SUE: 0.03
Qual. Beats: 0

Dividends

Dividend Yield	4.02%
Yield on Cost 5y	13.76%
Yield CAGR 5y	9.16%
Payout Consistency	93.9%
Payout Ratio	1.7%

Risk via 5d forecast
Volatility	34.9%
Value at Risk 5%th	57.6%
Relative Tail Risk	0.25%

Reward TTM
Sharpe Ratio	-0.62
Alpha	-39.29
CAGR/Max DD	0.55

Character TTM
Hurst Exponent	0.524
Beta	1.032
Beta Downside	1.266

Drawdowns 3y
Max DD	39.03%
Mean DD	10.03%
Median DD	5.21%

Description: IRM Iron Mountain December 17, 2025

Iron Mountain Inc. (NYSE: IRM) provides information-management services to over 240,000 customers across 61 countries, covering roughly 95 % of the Fortune 1000. Its portfolio spans physical and digital records storage, data-center colocation, secure shredding, and asset-lifecycle solutions, all built on a foundation of safety, security, sustainability, and ongoing innovation.

Key metrics that shape IRM’s outlook include a ~ 10 % year-over-year growth in digital-storage revenue (driven by enterprise cloud-migration and regulatory data-retention mandates) and a ~ 7 % operating margin expansion from 2022-2024 as the company leverages higher-value digital services. The REIT’s performance is also sensitive to macro-factors such as corporate capital-expenditure cycles, data-privacy legislation (e.g., GDPR, CCPA), and the broader demand for secure, off-site data-center capacity amid rising cyber-risk concerns.

For a deeper, data-driven assessment of IRM’s valuation and risk profile, you might explore the analytics platform ValueRay, which aggregates real-time financial and sector data to help pinpoint high-expected-value opportunities.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (159.3m TTM) > 0 and > 6% of Revenue (6% = 398.4m TTM)

FCFTA -0.06 (>2.0%) and ΔFCFTA -3.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -14.68% (prev -9.81%; Δ -4.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 1.27b > Net Income 159.3m (YES >=105%, WARN >=100%)

Net Debt (18.28b) to EBITDA (2.08b) ratio: 8.81 <= 3.0 (WARN <= 3.5)

Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (298.0m) change vs 12m ago 1.49% (target <= -2.0% for YES)

Gross Margin 55.63% (prev 56.43%; Δ -0.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 33.96% (prev 32.42%; Δ 1.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.28 (EBITDA TTM 2.08b / Interest Expense TTM 822.2m) >= 6 (WARN >= 3)

Altman Z'' -1.05

(A) -0.05 = (Total Current Assets 1.88b - Total Current Liabilities 2.86b) / Total Assets 20.63b

(B) -0.25 = Retained Earnings (Balance) -5.24b / Total Assets 20.63b

(D) -0.26 = Book Value of Equity -5.61b / Total Liabilities 21.24b

Total Rating: -1.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 41.69

1. Piotroski 2.0pt

2. FCF Yield -2.77%

3. FCF Margin -17.44%

4. Debt/Equity -20.95

5. Debt/Ebitda 8.81

6. ROIC - WACC (= 0.22)%

7. RoE -22.34%

8. Rev. Trend 98.67%

9. EPS Trend 48.78%

What is the price of IRM shares?

As of December 22, 2025, the stock is trading at USD 80.09 with a total of 6,057,700 shares traded.
Over the past week, the price has changed by -2.85%, over one month by -4.81%, over three months by -22.53% and over the past year by -21.14%.

Is IRM a buy, sell or hold?

Iron Mountain has received a consensus analysts rating of 4.10. Therefore, it is recommended to buy IRM.

Strong Buy: 4
Buy: 5
Hold: 0
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the IRM price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	115.7	44.5%
Analysts Target Price	115.7	44.5%
ValueRay Target Price	89.3	11.4%

IRM Fundamental Data Overview December 19, 2025

Market Cap USD = 23.47b (23.47b USD * 1.0 USD.USD)
P/E Trailing = 149.7925
P/E Forward = 43.1034
P/S = 3.5342
P/B = 1516.5122
P/EG = 1.08
Beta = 1.148
Revenue TTM = 6.64b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 15.49b USD (from longTermDebt, last quarter)
Short Term Debt = 699.3m USD (from shortTermDebt, last quarter)
Debt = 18.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.28b USD (from netDebt column, last quarter)
Enterprise Value = 41.75b USD (23.47b + Debt 18.48b - CCE 195.2m)
Interest Coverage Ratio = 1.28 (Ebit TTM 1.05b / Interest Expense TTM 822.2m)
FCF Yield = -2.77% (FCF TTM -1.16b / Enterprise Value 41.75b)
FCF Margin = -17.44% (FCF TTM -1.16b / Revenue TTM 6.64b)
Net Margin = 2.40% (Net Income TTM 159.3m / Revenue TTM 6.64b)
Gross Margin = 55.63% ((Revenue TTM 6.64b - Cost of Revenue TTM 2.95b) / Revenue TTM)
Gross Margin QoQ = 54.85% (prev 55.91%)
Tobins Q-Ratio = 2.02 (Enterprise Value 41.75b / Total Assets 20.63b)
Interest Expense / Debt = 1.14% (Interest Expense 209.7m / Debt 18.48b)
Taxrate = 16.14% (16.6m / 102.8m)
NOPAT = 883.3m (EBIT 1.05b * (1 - 16.14%))
Current Ratio = 0.66 (Total Current Assets 1.88b / Total Current Liabilities 2.86b)
Debt / Equity = -20.95 (negative equity) (Debt 18.48b / totalStockholderEquity, last quarter -882.0m)
Debt / EBITDA = 8.81 (Net Debt 18.28b / EBITDA 2.08b)
Debt / FCF = -15.79 (negative FCF - burning cash) (Net Debt 18.28b / FCF TTM -1.16b)
Total Stockholder Equity = -712.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.77% (Net Income 159.3m / Total Assets 20.63b)
RoE = -22.34% (negative equity) (Net Income TTM 159.3m / Total Stockholder Equity -712.8m)
RoCE = 7.13% (EBIT 1.05b / Capital Employed (Equity -712.8m + L.T.Debt 15.49b))
RoIC = 6.14% (NOPAT 883.3m / Invested Capital 14.39b)
WACC = 5.91% (E(23.47b)/V(41.94b) * Re(9.82%) + D(18.48b)/V(41.94b) * Rd(1.14%) * (1-Tc(0.16)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.50%
Fair Price DCF = unknown (Cash Flow -1.16b)
EPS Correlation: 48.78 | EPS CAGR: 6.26% | SUE: 0.27 | # QB: 0
Revenue Correlation: 98.67 | Revenue CAGR: 11.67% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=2.27 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+10.6%

Additional Sources for IRM Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle